In vivo Phenotypic Screening: Melior Discovery

By Natalie Foote, Director of Service Provider Operations, Science Exchange | blog.scienceexchange.com Phenotypic Screening Pioneer Launches Novel Analgesia Panel In this Provider Innovation Profile, we’re proud to feature Melior Discovery, a pioneer of in vivo phenotypic screening and a leader in the area of drug repositioning. Melior’s platform evaluates compounds through up to 40 different […]

Read More…